Trades on 3 secondary markets

Santa Ana Bio

Santa Ana Bio is a precision immunology company developing targeted therapies to stop autoimmune and inflammatory disease at the source. The company pairs a multi-omics discovery platform (integrating genomic, transcriptomic, and proteomic data) with a pipeline of bispecific and multi-specific antib

minimal 11.0 / 100 0 APIs View provider profile →

Company Biotechnology Immunology Autoimmune Disease Drug Discovery Precision Medicine

Santa Ana Bio is an API provider whose private shares are listed on 3 secondary markets: Forge Global, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.